How I treat chronic graft-versus-host disease

被引：168

作者：

Vogelsang, GB ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21231 USA

来源：

BLOOD | 2001年 / 97卷 / 05期

关键词：

D O I：

10.1182/blood.V97.5.1196

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Allogeneic stem cell transplantation (SCT) is now a commonplace procedure. Clinicians who care for patients with hematologic malignancies and aplastic anemia are almost certain to follow up patients after SCT This review is intended to help clinicians observe patients for probably the most important late complication of SCT, chronic graft-versus-host disease (GVHD). It reviews the pathophysiology, risk factors, clinical manifestations, evaluation, treatment, and supportive care of chronic GVHD. (Blood. 2001;97:1196-1201) (C) 2001 by The American Society of Hematology.

引用

页码：1196 / 1201

页数：6

共 34 条

[1] DIFFERENTIAL CYTOKINE EXPRESSION IN ACUTE AND CHRONIC MURINE GRAFT-VERSUS-HOST-DISEASE [J].

ALLEN, RD ;

STALEY, TA ;

SIDMAN, CL .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (02) :333-337

[2]

ATKINSON K, 1986, BONE MARROW TRANSPL, V1, P227

[3]

ATKINSON K, 1989, BONE MARROW TRANSPL, V4, P247

[4]

ATKINSON K, 1990, BLOOD, V75, P2459

[5]

BACIGALUPO A, 1990, BONE MARROW TRANSPL, V6, P341

[6]

BOLGER GB, 1986, BONE MARROW TRANSPL, V1, P21

[7] A EUROPEAN MULTICENTER STUDY OF CHRONIC GRAFT-VERSUS-HOST DISEASE - THE ROLE OF CYTOMEGALOVIRUS SEROLOGY IN RECIPIENTS AND DONORS - ACUTE GRAFT-VERSUS-HOST DISEASE, AND SPLENECTOMY [J].

BOSTROM, L ;

RINGDEN, O ;

JACOBSEN, N ;

ZWAAN, F ;

NILSSON, B .

TRANSPLANTATION, 1990, 49 (06) :1100-1105

[8]

BULLORSKY EO, 1993, BONE MARROW TRANSPL, V11, P75

[9]

DEGAST GC, 1991, BONE MARROW TRANSPL, V7, P293

[10]

DEWIT D, 1993, J IMMUNOL, V150, P361

← 1 2 3 4 →